Literature DB >> 30133302

Residual vascular dysfunction in women with a history of preeclampsia.

Anna E Stanhewicz1.   

Abstract

Preeclampsia is a hypertensive disorder of pregnancy characterized by new-onset hypertension, proteinuria, and edema occurring after 20 wk of gestation, with a prevalence of ~7-10% of pregnancies in the United States and ~8 million pregnancies worldwide. Despite the postpartum remission of preeclamptic symptoms, women who have had preeclampsia are two to four times more likely to develop cardiovascular disease (CVD) and are significantly more likely to die of CVD compared with women with a history of normal pregnancy. Although the relation between history of preeclampsia and elevated CVD risk is well documented, the mechanism(s) underlying this association remains unclear. One hypothesis explaining this association is that the initial vascular damage and dysfunction sustained during the preeclamptic pregnancy persist chronically. Indeed, even in the absence of, or in advance of, overt CVD women who have had preeclampsia have compromised vascular endothelial function. Emerging mechanistic studies in these women have provided some insight into the underlying mechanisms of this persistent vascular dysfunction and have begun to identify potential therapeutic targets for the prevention or mitigation of CVD progression in this vulnerable population. This review summarizes the existing literature examining vascular function and dysfunction in women with a history of preeclampsia and highlights future directions for mechanistic investigations and development of novel intervention strategies aimed at halting or slowing the progression of CVD in these women.

Entities:  

Keywords:  cardiovascular disease risk; endothelium; preeclampsia; vascular dysfunction

Mesh:

Year:  2018        PMID: 30133302      PMCID: PMC6734059          DOI: 10.1152/ajpregu.00204.2018

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  99 in total

1.  In vivo assessment of failed trophoblastic invasion of the spiral arteries in pre-eclampsia.

Authors:  R Matijevic; T Johnston
Journal:  Br J Obstet Gynaecol       Date:  1999-01

2.  Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure.

Authors:  B T Alexander; A N Rinewalt; K L Cockrell; M B Massey; W A Bennett; J P Granger
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

Review 3.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

Authors:  Naveed Sattar; Ian A Greer
Journal:  BMJ       Date:  2002-07-20

4.  Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.

Authors:  Patricia K Agatisa; Roberta B Ness; James M Roberts; Joseph P Costantino; Lewis H Kuller; Margaret K McLaughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04       Impact factor: 4.733

5.  Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans.

Authors:  J P Greenwood; E M Scott; J B Stoker; J J Walker; D A Mary
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

6.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Authors:  G Wallukat; V Homuth; T Fischer; C Lindschau; B Horstkamp; A Jüpner; E Baur; E Nissen; K Vetter; D Neichel; J W Dudenhausen; H Haller; F C Luft
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

7.  Association of maternal endothelial dysfunction with preeclampsia.

Authors:  J C Chambers; L Fusi; I S Malik; D O Haskard; M De Swiet; J S Kooner
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

8.  Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia.

Authors:  Makrina D Savvidou; Aroon D Hingorani; Dimitrios Tsikas; Jürgen C Frölich; Patrick Vallance; Kypros H Nicolaides
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

9.  Risk for subsequent coronary artery disease after preeclampsia.

Authors:  Leena Haukkamaa; Minna Salminen; Hannele Laivuori; Hannu Leinonen; Vilho Hiilesmaa; Risto Kaaja
Journal:  Am J Cardiol       Date:  2004-03-15       Impact factor: 2.778

Review 10.  Pregnancy: a stress test for life.

Authors:  David Williams
Journal:  Curr Opin Obstet Gynecol       Date:  2003-12       Impact factor: 1.927

View more
  11 in total

1.  Editors' Picks for 2018 demonstrate the diversity of research in regulatory, integrative, and comparative physiology.

Authors:  Willis K Samson; Roger G Evans; Wolfgang Langhans; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-06-05       Impact factor: 3.619

2.  The 2019 New Investigator Review Awards.

Authors:  Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-01-09       Impact factor: 3.619

3.  Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Lacy M Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

4.  Looking Back on Seven Years of Regulatory, Integrative and Comparative Physiology.

Authors:  Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-02-12       Impact factor: 3.619

5.  AJP-Regulatory, Integrative and Comparative Physiology: Looking Toward the Future.

Authors:  Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-05-06       Impact factor: 3.619

Review 6.  Differential and targeted vesiculation: pathologic cellular responses to elevated arterial pressure.

Authors:  Paul A Brown
Journal:  Mol Cell Biochem       Date:  2022-01-06       Impact factor: 3.396

7.  Acute systemic inhibition of inflammation augments endothelium-dependent dilation in women with a history of preeclamptic pregnancy.

Authors:  Anna E Stanhewicz; Gabrielle A Dillon; Corinna Serviente; Lacy M Alexander
Journal:  Pregnancy Hypertens       Date:  2021-12-28       Impact factor: 2.899

Review 8.  Maternal microvascular dysfunction during preeclamptic pregnancy.

Authors:  Anna E Stanhewicz; Virginia R Nuckols; Gary L Pierce
Journal:  Clin Sci (Lond)       Date:  2021-05-14       Impact factor: 6.876

9.  Characterisation of the Selective Reduced Uteroplacental Perfusion (sRUPP) Model of Preeclampsia.

Authors:  J S Morton; J Levasseur; E Ganguly; A Quon; R Kirschenman; J R B Dyck; G M Fraser; S T Davidge
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

10.  Long Non-coding RNA Gas5 Is Associated With Preeclampsia and Regulates Biological Behaviors of Trophoblast via MicroRNA-21.

Authors:  Dongying Zheng; Yue Hou; Yuanyuan Li; Yue Bian; Muhanmmad Khan; Fan Li; Ling Huang; Chong Qiao
Journal:  Front Genet       Date:  2020-03-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.